Xiao-Hu Fan

1.5k total citations
11 papers, 267 citations indexed

About

Xiao-Hu Fan is a scholar working on Oncology, Immunology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Xiao-Hu Fan has authored 11 papers receiving a total of 267 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 8 papers in Immunology and 2 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Xiao-Hu Fan's work include CAR-T cell therapy research (9 papers), Biosimilars and Bioanalytical Methods (5 papers) and Virus-based gene therapy research (2 papers). Xiao-Hu Fan is often cited by papers focused on CAR-T cell therapy research (9 papers), Biosimilars and Bioanalytical Methods (5 papers) and Virus-based gene therapy research (2 papers). Xiao-Hu Fan collaborates with scholars based in China, United States and Japan. Xiao-Hu Fan's co-authors include Sen Hong Zhuang, Wanhong Zhao, Jordan M. Schecter, Qiu-Chuan Zhuang, Jeffrey L. Goldberg, Yilin Zhang, Alicia J. Allred, Jesús G. Berdeja, Deepu Madduri and Jeffrey R. Infante and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Transplantation.

In The Last Decade

Xiao-Hu Fan

11 papers receiving 263 citations

Peers

Countries citing papers authored by Xiao-Hu Fan

Since Specialization

Citations

This map shows the geographic impact of Xiao-Hu Fan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiao-Hu Fan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiao-Hu Fan more than expected).

Fields of papers citing papers by Xiao-Hu Fan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiao-Hu Fan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiao-Hu Fan. The network helps show where Xiao-Hu Fan may publish in the future.

Co-authorship network of co-authors of Xiao-Hu Fan

This figure shows the co-authorship network connecting the top 25 collaborators of Xiao-Hu Fan. A scholar is included among the top collaborators of Xiao-Hu Fan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiao-Hu Fan. Xiao-Hu Fan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

#	Work	Indexed citations
1	Serum soluble BCMA can be used to monitor relapse of multiple myeloma patients after chimeric antigen receptor T-cell immunotherapy 2023 ·Current Research in Translational Medicine ·Ying Shen, Jie Liu, Baiyan Wang, Yilin Zhang, Yan Xu, Xiaman Wang, (unknown), Xin Meng, Xugeng Wang, Xiao-Hu Fan, Aili He, Wanhong Zhao	10
2	P874: LONG-TERM REMISSION AND SURVIVAL IN PATIENTS WITH RELAPSED OR REFRACTORY MULTIPLE MYELOMA AFTER TREATMENT OF LCAR-B38M CAR-T – AT LEAST 5-YEAR FOLLOW-UP IN LEGEND-2 2023 ·HemaSphere ·Jian‐Qing Mi, Wanhong Zhao, Lijuan Chen, Weijun Fu, Baiyan Wang, Jie Xu, Jie Liu, (unknown), Han Zhu, Juan Du, Hua Jiang, (unknown), (unknown), Xiao-Hu Fan, Jianyong Li, Jian Hou, Chen Zhu, Wanggang Zhang, Aili He, Sai‐Juan Chen	1
3	Antigen-induced chimeric antigen receptor multimerization amplifies on-tumor cytotoxicity 2023 ·Signal Transduction and Targeted Therapy ·Yan Sun, Xiuna Yang, (unknown), (unknown), Bing Zhang, Kaiwen Liu, Na Li, (unknown), (unknown), (unknown), Jie Xu, Jian‐Qing Mi, Chen Zhu, Xiao-Hu Fan, Sai‐Juan Chen, Shuo Chen	6
4	Long-term remission and survival in patients with relapsed or refractory multiple myeloma after treatment of LCAR-B38M CAR-T: At least 5-year follow-up in LEGEND-2. 2023 ·Journal of Clinical Oncology ·Jian‐Qing Mi, Wanhong Zhao, Lijuan Chen, Weijun Fu, Baiyan Wang, Jie Xu, Jie Liu, (unknown), Han Zhu, Juan Du, Hua Jiang, (unknown), (unknown), Xiao-Hu Fan, Jianyong Li, Jian Hou, Chen Zhu, Wanggang Zhang, Aili He, Sai‐Juan Chen	6
5	Phase II, Open-Label Study of Ciltacabtagene Autoleucel, an Anti–B-Cell Maturation Antigen Chimeric Antigen Receptor–T-Cell Therapy, in Chinese Patients With Relapsed/Refractory Multiple Myeloma (CARTIFAN-1) 2022 ·Journal of Clinical Oncology ·Jian‐Qing Mi, Wanhong Zhao, Hongmei Jing, Weijun Fu, Jianda Hu, Lijuan Chen, Yiwen Zhang, Dan Yao, (unknown), Jordan M. Schecter, Fan Yang, (unknown), (unknown), Sen Hong Zhuang, Jimmy Ren, Xiao-Hu Fan, Jie Jin, Ting Niu, Sai‐Juan Chen	42
6	Tri-Specific CD19xCD20xCD22 VHH CAR-T Cells (LCAR-AIO) Eradicate Antigen-Heterogeneous B Cell Tumors, Enhance Expansion, and Prolong Persistence in Preclinical In Vivo Models 2021 ·Blood ·Zhe Zhou, Yue Han, (unknown), (unknown), (unknown), Chong Feng, Hui Xiao, Qiu-Chuan Zhuang, (unknown), Xiao-Hu Fan	10
7	Results from CARTITUDE-1: A Phase 1b/2 Study of JNJ-4528, a CAR-T Cell Therapy Directed Against B-Cell Maturation Antigen (BCMA), in Patients with Relapsed and/or Refractory Multiple Myeloma (R/R MM) 2019 ·Blood ·Deepu Madduri, Saad Z. Usmani, Sundar Jagannath, Indrajeet Singh, Enrique Zudaire, Tzu‐Min Yeh, Alicia J. Allred, Arnob Banerjee, Jeffrey L. Goldberg, Jordan M. Schecter, Sen Hong Zhuang, Jeffrey R. Infante, Syed Rizvi, Xiao-Hu Fan, Andrzej Jakubowiak, Jesús G. Berdeja	83
8	Management of cytokine release syndrome related to CAR-T cell therapy 2019 ·Frontiers of Medicine ·Hongli Chen, Fangxia Wang, Pengyu Zhang, Yilin Zhang, Yinxia Chen, Xiao-Hu Fan, Xing-Mei Cao, Jie Liu, Yun Yang, Baiyan Wang, Bo Lei, Liufang Gu, Ju Bai, Lili Wei, Ruili Zhang, Qiu-Chuan Zhuang, Wanggang Zhang, Wanhong Zhao, Aili He	77
9	Preclinical assessment of LCAR-B38M, a novel BCMA-targeting chimeric antigen receptor (CAR)-T cell therapy in relapsed/refractory multiple myeloma 2019 ·Clinical Lymphoma Myeloma & Leukemia ·Xiao-Hu Fan, Qiu-Chuan Zhuang, (unknown), (unknown), (unknown), (unknown), (unknown), Dong Geng	6
10	EMERGENCE OF ANTI-INFLAMMATORY MONOCYTES IN LONG-TERM SURVIVING HOSTS OF IL-10-TRANSDUCED LIVER ALLOGRAFTS 2001 ·Cytokine ·Xiao-Hu Fan, (unknown), (unknown), (unknown), Hirotaka Tashiro, Takemasa Sakaguchi, Hisao Ito, Toshimasa Asahara	1
11	PROLONGATION OF LIVER ALLOGRAFT SURVIVAL AFTER INTERLEUKIN-10 GENE TRANSDUCTION 24???48 HOURS BEFORE DONATION1 2000 ·Transplantation ·Hirotaka Tashiro, (unknown), (unknown), (unknown), (unknown), (unknown), Yasuhiro Fudaba, (unknown), Xiao-Hu Fan, Hisao Ito, Toshimasa Asahara	25

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact